发明名称 Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
摘要 Provided are compounds of Formula (I): wherein R2, R3, R13, L and D2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed herein.;
申请公布号 US8853409(B2) 申请公布日期 2014.10.07
申请号 US201213493616 申请日期 2012.06.11
申请人 Array BioPharma Inc. 发明人 Aicher Thomas Daniel;Boyd Steven Armen;Chicarelli Mark Joseph;Condroski Kevin Ronald;Fell Jay Bradford;Fischer John P.;Gunawardana Indrani W.;Hinklin Ronald Jay;Singh Ajay;Turner Timothy M.;Wallace Eli M.
分类号 A61K31/44;C07D417/00;C07D417/14;C07D417/12;C07D213/75 主分类号 A61K31/44
代理机构 Viksnins Harris & Padys PLLP 代理人 Viksnins Harris & Padys PLLP ;Mastous Sarah S.
主权项 1. A compound of general Formula I or a salt thereof, wherein: R13 is a polyhydroxy-(2-6C) alkyl, methoxy(polyhydroxy-(3-6C)alkyl) or polyhydroxy-(5-6C)cycloalkyl; L is O or S; D2 is N or CH; R2 is Ar1, hetAr1, hetAr2, or hetAr3; Ar1 is phenyl or naphthyl, each of which is optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, CF3, OH, CN, SO2Me, C(═O)NH(1-3C alkyl)N(alkyl)2 and C(═O)NH(1-3C alkyl)hetCycl; hetAr1 is a 5-6 membered heteroaryl group having 1-3 ring nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C alkyl), Cl, CF3 and (1-6C alkyl)OH; hetAr2 is a partially unsaturated 5,6 or 6,6 bicyclic heteroaryl ring system having 1-2 ring nitrogen atoms and optionally having a ring oxygen atom; hetAr3 is a 9-10 membered bicyclic heteroaryl ring having 1-3 ring nitrogen atoms; R3 is Cl, Br, CF3, aryl, hetAra, SR6 or OR6; hetAra is a 6-membered heteroaryl having 1-2 ring nitrogen atoms; R6 is Ar2, hetAr4, (1-6C alkyl), -(1-6C alkyl)OH, polyhydroxy(1-6C alkyl), —CH(R9)—Ar3, —CH(R10)-hetAr5, hetAr6, (5-6C)cycloalkyl substituted with 1 to 4 OH, (1-3 C alkoxy)(1-6C alkyl), or cyclopropyl(1-6C alkyl); Ar2 is phenyl optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF3, CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3Calkyl)2 and C(═O)NH(1-3C alkyl)hetCyc2; hetAr4 is a 5-6 membered heteroaryl ring having 1-3 nitrogen atoms and optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF3, CN, OH, O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl), C(═O)NH(1-3C alkyl)N(1-3Calkyl)2 and C(═O)NH(1-3C alkyl)hetCyc2; Ar3 is phenyl optionally substituted with one or more groups independently selected from F, Cl, Br, and (1-6C)alkyl; hetAr5 is a 5-6-membered heteroaryl having 1-2 ring nitrogen atoms; hetAr6 is a 9-10 membered bicyclic heteroaromatic ring having 2-3 heteroatoms independently selected from N, S and O (provided the ring does not contain an O—O bond) which is optionally substituted with one or more groups independently selected from (1-6C)alkyl, F, Br, Cl, CF3, CN, OH, —O-(1-6C alkyl), C(═O)OH, C(═O)O(1-6C alkyl) and C(═O)NH(1-3C alkyl)N(1-3Calkyl)2; R9 and R10 are independently hydrogen, (1-6C)alkyl, (1-6C)alkylOH, or CF3; and hetCyc1 and hetCyc2 are independently a 5-7 membered heterocyclic ring having 1-2 ring heteroatoms independently selected from N and O.
地址 Boulder CO US
您可能感兴趣的专利